Results 201 to 208 of about 15,525 (208)

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

Nature, 1998
Lewis L Lanier, Kalle Soderstrom, Andrew J Mcmichael   +2 more
exaly  

The Inhibitory Receptor NKG2A Sustains Virus-Specific CD8+ T Cells in Response to a Lethal Poxvirus Infection

Immunity, 2015
Susan Gilfillan, Gaelle Le Friec, Marina Cella   +2 more
exaly  

Regulation of Activated CD4+ T Cells by NK Cells via the Qa-1–NKG2A Inhibitory Pathway

Immunity, 2007
Linrong Lu, Miriam Werneck, Harvey Cantor   +2 more
exaly  

High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer

OncoImmunology, 2017
Cheng Sun, Jing Xu, Hao Wen
exaly  

Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells

Journal of Clinical Investigation, 2019
Desmond Wong, Murray O Robinson, Dario Campana   +2 more
exaly  

Monalizumab. Anti-NKG2A monoclonal antibody, Checkpoint inhibitor, Cancer immunotherapy

Drugs of the Future, 2019
openaire   +1 more source

Targeting the aminopeptidase ERAP enhances antitumor immunity by disrupting the NKG2A-HLA-E inhibitory checkpoint

Immunity
Susan Klaeger, Suzanna Rachimi, Juan Dubrot   +2 more
exaly  

Developing enhanced immunotherapy using NKG2A knockout human pluripotent stem cell-derived NK cells

Cell Reports
Xianwei Chen, Vaithilingaraja Arumugaswami, Yanhong Shi   +2 more
exaly